Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest Sensorineural hearing loss Stories

2010-10-19 07:37:17

Vision and Hearing Leader Reveals Revolutionary Hearing Technology at Renowned Event Bonita Springs, FL (Vocus) October 19, 2010 PHSI, Physician Hearing Services, Inc., the unquestioned leader in Vision-Hearing programs, announces a breakthrough in the industry with the introduction of the patented 'Clarujust' hearing instrument fitting system. This innovative technology which is based on the mathematical decomposition of speech phonemes, is now offered by PHSI and will be available...

2010-03-17 14:12:00

Esteem approved to treat sensorineural hearing loss SILVER SPRING, Md., March 17 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today announced the approval of the Esteem - an implanted hearing system used to treat moderate to severe sensorineural hearing loss, a type of permanent hearing loss. (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO) Sensorineural hearing loss is usually caused by genetic factors or damage to the inner ear resulting from noise,...

2010-03-17 14:02:00

MINNEAPOLIS, March 17 /PRNewswire/ -- On March 17, 2010 the FDA gave approval to Envoy Medical Corporation to market a "First of its Kind" prosthetic hearing restoration device. The approval follows a December 18, 2009 unanimous 15 to 0 vote by an independent advisory panel in favor of approving the Esteem® for moderate to severe sensorineural hearing loss. The FDA chose an expedited review process, noting that they believe the Esteem® "represents a...

2010-02-17 07:00:00

SAN DIEGO, Feb. 17 /PRNewswire/ -- Otonomy, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of the company's Investigational New Drug (IND) application for the clinical trial of OTO-104 in patients with Meniere's disease, a debilitating disorder of the inner ear affecting balance and hearing. The FDA clearance enables Otonomy to move forward with the first clinical trial of a sustained release drug delivered by direct otic injection. Using an...

2010-02-16 08:02:17

Surgically implanted hearing aids anchored to the skull bone appear to be a durable treatment option that noticeably improves hearing among children with deafness in one ear, according to a report in the February issue of Archives of Otolaryngology -- Head & Neck Surgery, one of the JAMA/Archives journals. Single-sided deafness, also known as profound unilateral sensorineural hearing loss, affects between 0.1 percent and 3 percent of children, according to background information in the...

2009-12-21 15:10:00

ST. PAUL, Minn., Dec. 21 /PRNewswire/ -- Envoy Medical, a Minnesota corporation, has developed the first Fully Implantable Hearing Restoration System known as the Esteem®. On December 18th, an Advisory Panel of independent ENT experts unanimously recommended that the FDA approve the Esteem®. Patrick Spearman, Envoy Medical's Chief Executive Officer, was quoted as saying "This is great news for all sensorineural hearing loss sufferers. Envoy has been...

2009-10-12 23:01:00

SAN MATEO, Calif., Oct. 13 /PRNewswire/ -- Sonitus Medical, Inc., a medical device company developing the world's first non-surgical and removable hearing device to transmit sound via the teeth, today announced that technology it developed was ranked #1 on Cleveland Clinic's Top 10 Medical Innovations for 2010. The SoundBite(TM) hearing system is an investigational new bone conduction device intended initially for single sided deafness (SSD), a usually permanent condition. The 'Top...

2009-08-19 18:11:00

SEATTLE, Aug. 19 /PRNewswire/ -- Sound Pharmaceuticals (SPI) has received a $2.1 million research and development award from the Office of Naval Research, Science and Technology Division. This new funding will expand the ongoing development of SPI-1005 in to other areas of sensorineural hearing loss. SPI-1005, an oral form of a glutathione peroxidase mimic, is currently being tested in a Ph-II clinical trial aimed to protect and treat blast exposed active duty personnel in the Dept. of...

2009-07-10 08:00:00

DENVER, July 10 /PRNewswire/ -- Cochlear Americas announced today that the U.S. Food and Drug Administration (FDA) has cleared the Cochlear(TM) Baha(R) BP100 Sound Processor, the industry's first programmable bone conduction hearing solution. The Baha BP100 is an excellent choice for many children and adults with conductive hearing loss, mixed hearing loss or single-sided sensorineural deafness. The Baha BP100 improves upon previous systems by offering users the industry's first bone-...

2009-07-01 08:36:44

 An otherwise effective treatment for cystic fibrosis places patients at a high risk of sensorineural hearing loss, according to new research published in the July edition of Otolaryngology-Head and Neck Surgery.Cystic fibrosis is an inherited chronic disease that affects the lungs and digestive system of about 30,000 children and adults in the United States (70,000 worldwide). A defective gene and its protein product cause the body to produce unusually thick, sticky mucus that clogs the...